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The osteoinductive property of strontium was repeatedly proven in the last decades.
Compelling in vitro data demonstrated that strontium hydroxyapatite nanoparticles
exert a dual action, by promoting osteoblasts-driven matrix secretion and inhibiting
osteoclasts-driven matrix resorption. Recombinant human bone morphogenetic protein
2 (rhBMP2) is a powerful osteoinductive biologic, used for the treatment of vertebral
fractures and critically-sized bone defects. Although effective, the use of rhBMP2
has limitations due its recombinant morphogen nature. In this study, we examined
the comparison between two osteoinductive agents: rhBMP2 and the innovative
strontium-substituted hydroxyapatite nanoparticles. To test their effectiveness, we
independently loaded Gelfoam sponges with the two osteoinductive agents and used the
sponges as agent-carriers. Gelfoam are FDA-approved biodegradable medical devices
used as delivery system for musculoskeletal defects. Their porous structure and spongy
morphology make them attractive in orthopedic field. The abiotic characterization of the
loaded sponges, involving ion release pattern and structure investigation, was followed
by in vivo implantation onto the periosteum of healthy mice and comparison of the
effects induced by each implant was performed. Abiotic analysis demonstrated that
strontiumwas continuously released from the sponges over 28 days with a pattern similar
to rhBMP2. Histological observations and gene expression analysis showed stronger
endochondral ossification elicited by strontium compared to rhBMP2. Osteoclast activity
was more inhibited by strontium than by rhBMP2. These results demonstrated the use
of sponges loaded with strontium nanoparticles as potential bone grafts might provide
better outcomes for complex fractures. Strontium nanoparticles are a novel and effective
non-biologic treatment for bone injuries and can be used as novel powerful therapeutics
for bone regeneration.
Keywords: strontium hydroxyapatite nanoparticles, BMP2, osteoporosis, scaffold, endochondral ossification,
bone regeneration
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INTRODUCTION
Bone tissue constitutes the rigid scaffold that is the skeleton,
which provides structural support for vertebrates and confers
protection to the most delicate vital organs. The extraordinary
regenerative capability of bone tissue to repair and heal without
the formation of a fibrotic scar was recognized by Imhotep
(2630–2611 BC) and Hippocrates (460–370 BC) (Lanza and
Vegetti, 1974). However, in pathological conditions such as
osteoporosis, sever bone trauma or critically-sized bone defects
this process can be hindered, leading to delayed healing and/or
non-union fractures (Holroyd et al., 2008; Sozen et al., 2017).
These unsolicited outcomes constitute an often underestimated
burden for our society, in term of quality of life, recovery time and
costs for the healthcare system (Gentleman et al., 2010; Marcus,
2007).
Bone tissue engineering focuses on the creation of devices
capable of providing physical support, activating bone forming
cells (concepts, respectively, defined as osteoconductivity and
osteoinductivity) with the aim of assisting and accelerating
osteogenesis (Dennis et al., 2015; Kowalczewski and Saul, 2018).
During the last two decades in vitro and in vivo studies were
designed to identify novel scaffolding systems for a topical and
controlled delivery of osteoinductive agents (Landi et al., 2007;
Visai et al., 2017; Chandran et al., 2018). Many of them focused
on the employment of recombinant human bone morphogenic
protein 2 (rhBMP2) as a powerful osteoinductive agent (Wang
et al., 1990; Buza and Einhorn, 2016). A great amount of
effort has been placed in investigating rhBMP2 suitability as
treatment for conditions such as spinal fractures and critically-
sized bone defects (Noshi et al., 2001; Boix et al., 2005).
Several studies highlighted the benefits of using this recombinant
morphogen, but also its side effects (Wang et al., 1990; Noshi
et al., 2001). Local side effects (such as insufficient or excessive
bone formation, heterotopic bone formation, infections and
inflammatory responses) as well as systemic ones (cancer in
a relatively low percentage of cases) were identified in several
independent studies (Boraiah et al., 2009; Latzman et al., 2010;
Hoffmann et al., 2013; Woo, 2013; Poon et al., 2016). Compelling
experimental results showed the efficacy of strontium cations,
as osteoinductive and anti-osteoporotic agents (Rohnke et al.,
2016; Carmo et al., 2018; Li et al., 2018). Strontium modulates
bone remodeling by enhancing bone formation and suppressing
bone resorption (Chattopadhyay et al., 2006; Takaoka et al.,
2010; Yang et al., 2011; Saidak and Marie, 2012; Tian et al.,
2014) although, to date, the molecular and cellular mechanisms
of strontium activity remain partially elusive. Physical-chemical
properties of strontium-substituted hydroxyapatite nanoparticles
in combination with calcium hydroxyapatite nanoparticles and
their in vitro osteoinductivity were assessed in our previous
works (Frasnelli et al., 2016; Visai et al., 2017; Cristofaro et al.,
2019).
Abbreviations: ECM, extracellular matrix; OBs, osteoblasts; OCs, osteoclasts;
CaSR, calcium sensing receptor HAn, calcium hydroxyapatite nanoparticles;
SrHAn, mixture of 90% calcium hydroxyapatite nanoparticles and 10% strontium
hydroxyapatite nanoparticles.
In this work we utilized new nanotechnology to design a
novel nanomaterial that is absent of recombinant morphogen
yet still possess bone healing properties exerted by strontium
to be used as an application for orthopedic surgery. This
nanomaterial is a combination of strontium-substituted and
calcium hydroxyapatite nanoparticles which was delivered in
vivo by Gelfoam sponges, an FDA-approved collagen-based
sponge commonly used as hemostatic application on bleeding
surfaces (Pharmacia and Upjohn Company and Pfizer, 2017).
The combination between the porous structure and molecular
composition made it attractive in the orthopedic field and
suitable either for morphogens or for ceramics delivery
(Rohanizadeh et al., 2008; Giorgi et al., 2017).
The aim of this work is to compare the in vivo osteogenesis
of strontium hydroxyapatite nanoparticles (SrHAn) to calcium
hydroxyapatite nanoparticles and rhBMP2 (HAn-BMP2) using
Gelfoam sponges as carriers with both treatments. An extensive
characterization was performed including an abiotic study on
the implant structure, as well as analysis of ions and rhBMP2
release patterns. The in vivo study was performed, on a healthy,
bone damage-free mouse model to analyze the effectiveness of
the described implants in targeting bone tissue. The sponges were
implanted adjacent to the periosteum and gene expression of
markers of osteocytes and OCs maintenance, MSCs recruitment,
osteogenic and chondrogenic differentiation were evaluated, in
order to analyze the responses at the periosteal bone. The
experimental scheme is shown in Figure 1, with the comparison
between SrHAn and HAn-BMP2. Sponges loaded with only
calcium hydroxyapatite nanoparticles (HAn) were used as the
negative control. In the study we included also the stability
assessment of lyophilized samples, as this lyophilization could be
suitable for the packaging and distribution of the implants.
MATERIALS AND METHODS
Standard Sponges Loading Protocol
Gelfoam sponges (Gelfoam; Pfizer R©, NY, USA) were cut into
1 cm2. The sponge absorbance capacity of 200 µL was defined
as the volume of water completely absorbed by each sponge.
The sponges were loaded with a HCl-acidified MilliQ water
solution (pH 5) containing 30% (w/v) of calcium hydroxyapatite
nanoparticles (HAn) or with a MilliQ water solution containing
27% (w/v) of HAn and 3% (w/v) of strontium hydroxyapatite
nanoparticles (SrHAn). For abiotic characterization unloaded
sponges were hydrated with acidified MilliQ and defined as
the control (CTRL). For rhBMP2 loaded-sponges, 3 µg of
human recombinant BMP2 (R&D Systems) were added to the
HAn suspension before the sponge absorption phase (HAn-
BMP2). Acidified MilliQ was used to increase nanoparticles
solubility, buffer pH suspension (otherwise alkaline) and to
prevent rhBMP2 precipitation (Friess et al., 1999; Luca et al.,
2010). The CTRL, HAn, HAn-BMP2 and SrHAn samples were
incubated at room temperature (RT) in a 24-well plate for 15min
after loading to allow the volume to be adsorbed. Following
30min of incubation at 37◦C, in a humidified and controlled
atmosphere, with 5% CO2, the wells were filled with 800 µL of
acidified MilliQ.
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FIGURE 1 | Schematic representation of abiotic and in vivo sponge characterization. The collagen sponges were loaded with calcium hydroxyapatite nanoparticles
(HAn), with calcium hydroxyapatite nanoparticles + BMP2 (HAn-BMP2), and a mixture of calcium hydroxyapatite nanoparticles and strontium hydroxyapatite
nanoparticles (SrHAn). Sponge characterization was achieved by several physical-chemical techniques. X-ray observations and Fast green/Safranin-O histological
staining were performed on tissue samples collected from the in vivo experiments. Expression of genes for osteogenesis, osteocytes and osteoclasts activity,
chondrogenesis, and stem cell recruitment was also investigated. Figure created with BioRender.com.
A second set of sponges was prepared exactly as the first set
of samples but with an additional step of lyophilization in order
to check the system stability. Exception made for HAn-BMP2,
which was not prepared in the second set. This second set was
labeled with an “s” for “stability” (sCTRL, sHAn, sSrHAn) and
collectively defined as “treated” sponges. Following the second
incubation period carried out in 800 µL of acidified water, all
samples were frozen O/N at −20◦C and lyophilized for 4 h
(−50◦C, 0.3 mbar). Following lyophilization samples were re-
hydrated with 200 µL of acidified MilliQ. For both sets of
sponges, water solutions were poured off and fresh non-acidified
MilliQ water was added on day 1, 2, 3, 7, 14, 21, and 28.
Sponge Calcium, Strontium, and BMP-2 Release
Water solution samples were collected at 1, 2, 3, 7, 14, 21,
and 28 days from untreated sponges (CTRL, HAn, SrHAn),
treated sponges (sCTRL, sHAn, sSrHAn) and from sponges
loaded simultaneously with HAn and rhBMP2 (HAn-BMP2).
For the analysis, each sample replicate (1mL) was diluted 1:10
and acidified with suprapur nitric acid (Merck - Sigma Aldrich,
Merck KGaA, Darmstadt, Germany) at the final concentration
of 0.5% (v/v), centrifuged and filtered with 0.45µm membranes.
Acidified water was used as blank (Moonesi Rad et al., 2019).
Measurements were performed using an ICP-OES (inductively
coupled plasma optical emission spectroscopy) iCAP 7000 Series
(Thermo Scientific) following the standard procedures suggested
by the manufacturer and an instrumental method already
validated. Calcium and strontium were quantified by external
calibration with four standard solutions (0, 5, 1, 5, 10, and 20
mg/L) of the alkaline earth standard metal mix TraceCERT R©
(100 mg/L). The following wavelengths were selected for the
investigated elements: 422,673 nm for Ca2+ and 407,771 nm
for Sr2+. Time zero corresponds to the acidified water before
the introduction of the sponges. Statistical evaluation was
performed with one-way ANOVA. 95% confidence intervals
showing the differences between averaged values were plotted in
separated charts, reported as (Figure S2). rhBMP2 release rate
was evaluated by ELISA. rhBMP2 release in the water solutions
was measured after addition of 20mM monosodium phosphate,
in order to displace rhBMP2 from its binding with HAn (Urist
et al., 1984; Boix et al., 2005). Samples were then centrifugated to
remove excess calcium and 100 µL of each solution was used for
immobilization on ELISA wells. Anti-rhBMP2 polyclonal rabbit
IgG (ReliaTech GmgH) was used on dilution factor of 1:3,000.
Goat anti-rabbit/HRP (Agilent Tech) secondary antibody was
used at 1:5,000 dilution. Reaction was developed with TMB
(Sigma T0440−100mL) for 30min at RT, stopped with sulfuric
acid 0.5M and ELISA microplate was read with Clariostar ELISA
reader at 450 nm. (HAn, SrHAn, sHAn and sSrHAn).
FT-IR Spectroscopy Investigation of
Sponge-Nanoparticles Interactions
FT-IR (Fourier Transform-Infra Red) spectra were obtained
using a Nicolet FT-IR iS10 Spectrometer (Nicolet, Madison,
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WI) equipped with attenuated total reflectance sampling
accessory (Smart iTR with diamond plate) by coadding 32
scans in the 4,000–650 cm−1 range with a resolution at
4 cm−1. FT-IR spectra were recorded on the unloaded
sponges, on the unloaded sponges blended together with the
nanoparticles (referred to as physical mixture, PM) and on the
nanoparticles loaded-sponges.
Sponge SEM Observations and Mineral Phase
Distribution
Untreated (CTRL, HAn, SrHAn) and treated (sCTRL, sHAn,
sSrHAn) sponges collected at time 0 days (T0) and time 28
days (T28) were frozen O/N at −20◦C and lyophilized for 3 h
(−50◦C, 0.3 mbar). Microscopic structure was investigated using
a scanning electron microscope (SEM) Zeiss EVO-MA10 (Carl
Zeiss, Oberkochen, Germany). Images were acquired at different
magnifications (150x and 350x) and at an accelerating voltage of
20 kV. CTRL, HAn and SrHAn sponges were also investigated
with SEM Zeiss EVO-MA10 (Carl Zeiss, Oberkochen, Germany)
coupled to an electron dispersive spectroscopy (EDS) (X-max 50
mm2, Oxford Instruments, Oxford, UK). Images were acquired
at a lower magnification and energy dispersive microanalysis was
performed in order to map phosphorus (P), calcium (Ca) and
strontium (Sr) and quantify carbon (C), oxygen (O), P, ca and Sr.
Sponge Degradation Rate Measurement
To evaluate the sponge degradation rate, untreated unloaded
and loaded sponge masses were measured at the following time
points: 1, 2, 3, 7, 14, 21, and 28 days. Sponges were prepared
as described above. Day 0 corresponded to the untreated and
unloaded dried sponge, while day 1 corresponded to loaded
sponges. Weights at day 1 were assumed as the initial weights
(Wi) and percentage weight loss was calculated for each point.
The calculation performed is the following: [(Wi-Wt)/Wi]∗100,
were Wt is the weight at each time point. Average and standard
deviation of the percentage weight loss were plotted.
In vivo Animal Study
All animal studies were approved by the Institutional
Animal Care and Use Committee at Boston University
(BU). Animals enrolled for these studies were crosses of the
B6.Cg-Gt(ROSA)26sortm14(CAG-tdTomato)Hze/J (Ai14;
stock number 007914) mouse strain with either B6.CG-
Pax7tm1(cre/ER2)Gaka/J (Pax7; stock number 017763) or
Prx1CreER-GFP (Kawanami et al., 2009). The Ai14 and Pax7
stains were obtained from The Jackson Laboratory (Bar Harbor
ME) and housed at the BU animal facilities under standard
conditions. All enrolled for this study were healthy, bone
damage-free, male mice aged 9–11 weeks. Strains were randomly
assigned to treatment and time point.
Sponge Implant Surgical Procedure and in vivo
Analysis
The previously prepared untreated samples (HAn, SrHAn, and
HAn-BMP2) were used for in vivo animal studies. Mice were
bilaterally implanted as described before with the exception
that the sponges were implanted instead of demineralized
bone matrix to induce ectopic bone formation adjacent to the
periosteal surface of femurs (Bragdon et al., 2017). Three mice
were enrolled per condition per time point (post-operative
day 16 and 33) for RNA extraction and histology analysis.
Figure 1 shows a scheme of the performed experiment. No
complications and/or collateral effects arose in that period. At
post-operative day 16 and 33 mice were euthanized by carbon
dioxide inhalation followed by cervical dislocation. Immediately
following euthanasia, mice were X-rayed using Faxitron MX-
20 Specimen Radiography System at 30 kV for 40 s using
Kodak BioMax XAR Scientific Film. The implanted sponge
and femur from the left limb were collected separately for
RNA extraction and gene analysis. Samples harvested for RNA
analysis were stored at −80◦C. The right limb was recovered for
histology analysis.
Histological Analysis of Mouse Limb
After fixation in paraformaldehyde (4%), the right limbs were
decalcified in 14% w/v EDTA (pH 7.2) for 1 week at 4◦C. Limbs
were dehydrated and embedded in paraffin for histology and 5
µm-thick sections were cut across the samples. Fast green and
Safranin-O (American Mastertek Inc.) staining was performed
on the 5 µm-thick sections for the investigation of ectopic bone
formation (Provot and Schipani, 2005).
RNA Extraction and Quantitative Reverse
Transcriptase PCR
RNA extraction was performed by tissue dissociation and
chemical extraction as previously described (Bragdon et al.,
2017). Briefly, samples were snap frozen in QIAzol R© Lysis
Reagent and lysed with the Qiagen R© Tissue Lyser II. Chloroform
(Sigma-Aldrich) and isopropanol (Sigma-Aldrich) was used to
extract and precipitate RNA followed by 70% ethanol washes.
The RNA was re-suspended in 30–50 µL of RNase free water
and stored at −80◦C. In order to ensure the quality and
quantity of the extracted RNA, both spectroscopy and gel
electrophoresis were used. For the spectroscopy, a Beckman
CoulterTM DU R©530 Life Science UV/Vis Spectrophotometer
was used and a 260 nm/280 nm ratio value in the range of
1.7–1.9 indicated an acceptable quality of RNA. The 260 nm
absorbance value was used to determine the concentration of
RNA in the samples. RNA samples were loaded into a 1% agarose
gel, GelStarTM Nucleic Acid Gel Stain from Lonza Group was
used to detect the presence of the nucleic acid. The presence of
two bands under UV light indicates the RNA is intact and not
degraded (data not shown). cDNAwas synthesized and qRT-PCR
was performed as previously described (Bragdon et al., 2017).
Briefly, 1 µg of extracted RNA was reverse transcribed using
the TaqMan R© Reverse Transcription Reagents kit from Applied
Biosystems R©. Primers used to probe specific expression of genes
are listed in Table 1. The 18S gene was used as a reference gene
and in addition to our samples non-operative femurs were used
as naïve controls. Target gene expression was normalized using
the11Ct method of Schmittgen and Livak (2008).
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TABLE 1 | qRT-PCR gene primers.
Primer Catalog number
NORMALIZATION PRIMER
18S Mm03928990_gl
STEM CELL RECRUITMENT PRIMER
Nanog Mm02384862_gl
CHONDROGENESIS PRIMERS
Sox9 Mm00448840_ml
Col10A1 Mm00487041_ml
Acan Mm00545794_ml
OSTEOGENIC- ASSOCIATED PRIMERS
BGlap Mm03413826_mH
Runx2 Mm00501578_ml
Dmp1 Mm00803833_gl
Sp7 Mm04209856_sl
Ibsp Mm00492555_ml
OSTEOCLASTS- ASSOCIATED PRIMERS
Acp5 Mm00475698_ml
Rankl Mm00441908_ml
Ctsk Mm00484039_ml
OSTEOCYTES- ASSOCIATED PRIMERS
Sost Mm00470479_ml
List of primers used during the in vivo investigation of genes crucial for the differentiation
and activity of cells residing in the bone. The genes are divided over their specificity and
their catalog number is reported beside.
Statistical Analysis
Statistical analyses were performed with Prism 7 (GraphPad
Software Inc). Means are plotted and standard deviations (SD) of
means, or standard error means (SEM) are represented by error
bars. One-way ANOVA corrected by Tukey’s honestly significant
difference (THSD) test was used to analyze data, if not otherwise
specified. A significance level of 0.05 was used for all statistical
analyses, unless noted differently.
RESULTS
Physical-Chemical Characterization of the
Loaded, Untreated, and Treated Sponges
Untreated sponges (CTRL, HAn, and SrHAn) were prepared
and physical-chemically characterized for degradation rate, ion
release properties by ICP-OES, sponge-nanoparticles interactions
by FT-IR and morphology by SEM. Furthermore, a stability
assessment was performed on the treated (lyophilized) sponge
samples (sCTRL, sHAn, sSrHAn).
The absolute amounts of calcium and strontium loaded
onto each sponge was then calculated. 60mg of HAn contains
23.89mg of calcium whereas 54mg + 6mg of SrHAn contains
21.5mg of calcium and 3.55mg of strontium. Calcium mass
for HAn-BMP2 sponge was calculated as for the HAn sample
and corresponds to 23.89mg. ICP-OES data of the water
solutions collected at different time points from untreated
samples (Figure 2 and Table 2) was used to evaluate the
progressive release of calcium and strontium ions in solution.
For HAn-BMP2 samples, calcium ions and rhBMP2 release were
measured via ICP-OES and indirect ELISA assay, respectively
(Figures 2C,D and Table 2). An initial burst of Ca2+ release
was reported for samples HAn and SrHAn (Figures 2A,B), and
this was followed by a significant decrement at day 3, after
which it stabilized at about 10mg/L—Table 2. A similar pattern
is presented also for strontium ions (Figure 2B), although the
concentration values was higher at day 3, ranging between
40 and 50mg/L—Table 2. In Han-BMP2 samples, calcium ion
release trend was flattened and strongly decreased (Figure 2C)
compared to the Han and SrHAn samples. This is probably due
to the presence of rhBMP2 in the same solution. Although, the
release of rhBMP2 showed a trend very similar to SrHAn samples,
with a concentration spike in the first 2 days followed by a
decrease at day 3 and constant release until day 28 (Figure 2D).
The ICP-OES analyses performed on samples treated for
stability assessments showed similar ion release patterns after the
lyophilization treatment (Figure S1 and Table S1). In particular,
for the sHAn sponges (Figure S1A), calcium ion release was
higher at day 3 reaching 30 and 40mg/L. Interestingly, sSrHAn
sponges showed a less intense burst at day 3 and increasing
values from day 7 to day 28 (Figure 2D). Although increments
in the days 7–28 were not significant (Figure S2). The 95%
confidence intervals of the ICP-OES average values are reported
in (Figure S2).
To evaluate sponge-nanoparticle interactions, FT-IR
spectroscopy was employed (Figure 3). Unloaded and untreated
sponge spectrum (Figures 3A,B) showed characteristic protein
peaks (Morris and Finney, 2004; Barth, 2007): NH stretching
band at 3271 cm−1; C=O stretching band (amide I) at
1,624 cm−1; N-H bending band (amide II) at 1,528 cm−1;
C-N stretching (amide III) at 1,232 cm−1. FT-IR spectra
(Figures 3C–J), showed the comparative analysis between
unloaded sponge blended along with nanoparticles (physical
mixture = PM; Figures 3C,D,G,H) and untreated sponges
loaded with nanoparticles (Figures 3E,F,I,J). All FT-IR spectra
of nanoparticles containing-specimens showed good agreement
with the characteristic PO43- (1,023 cm−1) and OH– (3,570
cm−1) vibrations of hydroxyapatite lattice as reported before
(Kim et al., 2002). Due to the low concentration of strontium
in the samples, no significant variations were recorded between
HAn_PM and SrHAn_PM, in accordance with previous
results (Frasnelli et al., 2016). However, protein bands showed
a much lower intensity in nanoparticles loaded sponges
(Figures 3E,F,I,J) and completely disappeared in PM spectra
(Figures 3C,D,G,H). While NH stretching band at 3,271 cm−1
was recorded only in the CTRL, C=O stretching and N-H
bending slightly moved from initial values (1,624 and 1,528
cm−1) to 1,650–1,631 cm−1, and 1,531–1,535 cm−1, respectively.
After lyophilization treatment (Figure S3), all protein bands
completely disappeared (Figures S3C–F).
SEM images were collected to analyze the morphology of
unloaded and loaded sponges (Figure 4). Unloaded sponges at
T0 (Figure 4A) were characterized by a spongy structure, with
interconnected pores and smooth wall surfaces. Loaded sponge
surfaces were rougher and more irregular (Figures 4B–D).
A reduction of wall surfaces occurred in the unloaded
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FIGURE 2 | Calcium, strontium and rhBMP2 release from loaded untreated sponges. ICP-OES data representation of calcium and strontium ions release from HAn,
HAn-BMP2, and SrHAn loaded sponges. Indirect ELISA was performed to quantify solubilized rhBMP2. Data were collected during the 28 days in aqueous solution.
Ca2+ released from HAn sponges (A); Ca2+ and Sr2+ released from SrHAn sponges (B); Ca2+ and rhBMP2 release from HAn-BMP2 sponges (C,D) N = 3 samples
were measure per each time point.
TABLE 2 | Tabular representation of the data shown in Figure 2.
Time (days) HAn SrHAn HAn-BMP2
Ca (mg/L) Ca (mg/L) Sr (mg/L) Ca (mg/L) rhBMP2 (µg/mL)
0 0 0 0 0 0
1 30.6 ± 3.5 29.5 ± 3.5 71.7 ± 3.8 3.8 ± 0.4 1.3 ± 0.133
2 16.9 ± 2.5 13.6 ± 2.4 51.1 ± 5.0 4.4 ± 0.5 1.29 ± 0.01
3 11.5 ± 1.7 7.5 ± 3.2 35.2 ± 4.7 3.3 ± 0.8 0.43 ± 0.06
7 13.0 ± 1.8 7.5 ± 2.0 46.9 ± 3.5 2.2 ± 0.4 0.38 ± 0.03
14 7.2 ± 0.6 6.3 ± 2.4 45.4 ± 2.9 2.2 ± 0.6 0.38 ± 0.03
21 5.2 ± 0.3 4.8 ± 4.0 42 ± 2.6 2.0 ± 0.6 0.44 ± 0.07
2 13.7 ± 2.8 10.5 ± 2.8 46.2 ± 3.3 1.7 ± 0.5 0.31 ± 0.06
Average concentration values and standard deviations of the calcium and strontium ions and of rhBMP2 measured in the different sponges.
samples after 28 days (Figure 4E), but it was not observed in
loaded samples (Figures 4F–H). A morphological change was
appreciated comparing the T0 and T28 (Figures 4B,C,E–H).
At T0 hydroxyapatite aggregates were detected on the sponge
walls, while at T28 sponge walls looked smoother and the whole
structure becamemore compact. Energy dispersivemicroanalysis
conducted on HAn and SrHAn samples (Figures 4I–L) showed a
homogenization of the phosphorus and calcium distribution on
the sponge surfaces after 28 days in aqueous solution (Figure 4,
P and Ca distribution maps). The same microanalysis performed
on CTRL sample did not show an appreciable level of P, Ca and
Sr (data not shown). Moreover, on HAn and SrHAn samples a
decrement in the weight percentage of calcium and strontium
was recorded at day 28 compared to day 0 (Figures 4M–P).
Regarding the treated samples (Figure S4), unloaded sponges
at T0 (Figure S4A) showed a morphology very similar to
untreated samples at T0 (Figure S4A). Even though, it is possible
to appreciate the formation of minor ripples, probably due to the
additional lyophilization phase. At T0, the treated and untreated
sponges reported similar structures. At T28, treated and loaded
sponges acquired a cement-like morphology (Figures S4F–H).
The degradation rate was determined by measuring the
sponge weight throughout 28 days in aqueous solution
(Figure 5). A slow degradation pattern was observed with no
significant variations recorded, except for the SrHAn loaded
sponges (Figure 5C). SrHAn samples registered a significant
difference in percentage weight loss between day 1 and day 28
(p< 0.0001).
A reduction in the quantities of calcium and strontium on
the sponge surfaces was recorded at day 28, in accordance
with ICP-OES data. Taken together these results indicated
the SrHAn loaded sponges are a stable system for a
constant and prolonged release of Ca2+ and Sr2+. They
are biodegradable and their morphology fits the golden
standard parameters for osteoconductive scaffolds. Although
lyophilization partially changed the morphology of the sponges
at T28, there was no significant change in calcium and
strontium release.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 6 June 2020 | Volume 8 | Article 499
Montagna et al. Strontium Hydroxyapatite Nanoparticles for Bone Regeneration
FIGURE 3 | IR evaluation of sponge-nanoparticles interactions. FT-IR spectra of sponges and nanoparticles physical mixtures (Han_PM and SrHAn_PM) (C,D,G,H)
were compared with spectra corresponding to the untreated and loaded sponges HAn and SrHAn at 28 days (E,F,I,J). In the panels a and b, FT-IR spectrum of
untreated and unloaded sponge was reported (CTRL). Spectra were divided in two sections: wavenumber range 4,000–3,000 cm−1 was reported in (A,C,E,G,I);
while wavenumber range 2,000–650 cm−1 was shown in (B,D,F,H,J).
In vivo Sponge’s Implantation and
Characterization of Their Effects
Next, sponges prepared following the standard protocol (HAn,
HAn-BMP2, and SrHAn) were utilized for in vivo implantation
to determine the osteogenic ability of the nanoparticles.
Radiography, macroscopic observations and histological staining
of bone tissues and implanted sponges were carried out to analyze
the sponge integration and surrounding tissue adaptation at post-
operative day 16 and 33. Gene expression analysis from the
implants and femurs were also performed at corresponding times
to determine the molecular responses.
The radiographic images support the macroscopic
observation that strong integration underwent between the
femur, sponge, and surrounding tissue (Figure 6). Within the
implanted sponges there were few visible blood vessels, as shown
in Figure 7. Implants and ectopic bones showed various degrees
of calcification, as shown by the radiographic images. The
sponges loaded with HAn-BMP2 and SrHAn appeared to show
increased calcified material than in the sponges with HAn alone.
The radiographic and macroscopic images also suggested that
there was a reduction in implant dimensions at day 33 compared
to day 16 (Figures 6A–C,J–L). Since the implants consisted
of sponge and hydroxyapatite (black arrowheads in Figure 6),
it was difficult to distinguish between the implanted material
and the formation of ectopic bone. However, the histological
analysis using Fast Green and Safranin-O stain demonstrated
the formation of both cartilage and bone tissue at the sponge
implant site (Figure 7).
More extended Safranin-O positive regions (indicated with
red arrowheads in Figure 7) were observed in the HAn and
SrHAn samples at 16 days. Whereas, at 33 days, no Safranin-O
positive tissue could be detected. This indicates that the ectopic
bone formed through the endochondral ossification process, with
cartilaginous tissue turning to calcified areas. The forming bone
tissue at the implant sites also appears to support hematopoiesis,
as shown by the recruitment of marrow cells between the femur
cortical bone and the sponge (Figure 7E). The newly formed
tissues (bone and bone marrow) were present in all implants
but in the SrHAn loaded sponges were more represented. At 33
days, (Figures 7G–L) ectopic bone tissue is shown with respect
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FIGURE 4 | The microscopic structure (150× and 350×) of the untreated CTRL (unloaded sponges), HAn, HAn-BMP2 and SrHAn (loaded sponges) samples is
shown in (A-H). Pictures represented samples at T0 (A–D) and after 28 days (E–H) of permanence in aqueous solutions, in a controlled and humidified atmosphere
(37◦C, with 5% of CO2). Untreated samples surfaces were also analyzed with SEM-EDS (Energy Dispersive X-Ray Spectroscopy) at 0 (I,J) and 28 days (K,L). Images
at low magnifications of the sponges were taken with SEM (I–L). The elements phosphorus (P), calcium (Ca) and strontium (Sr) were mapped on the same pictures
using different colors (P = green; Ca = red; Sr = white) and a black background. Quantification of the elements carbon (C), oxygen (O), phosphorus (P), calcium (Ca)
and strontium (Sr) present of the samples surface was performed and data were reported as weight percentage in the bar charts (M,N,O,P) histograms.
to control, accompanied by the presence of an area enriched in
bone marrow cellular components.
To investigate the changes in gene expression in both the
femur and implants after 16 and 33 days, tissues were harvested
separately from HAn, HAn-BMP2, and SrHAn implanted mice.
Figure 8 represents chondrogenesis (Acan, Col10A1, and Sox9)
and stem cell recruitment (Nanog) markers. While Figure 9
shows gene expression of markers for osteogenesis (Runx2, Sp7,
Ibsp, BGlap, andDmp1), osteocytes (Sost) andOCs activity (Acp5,
Rankl, and Ctsk). Acan (Aggrecan core protein), Col10A1 (Type
10 collagen) and Sox9 expression was analyzed as chondrogenesis
and endochondral ossification markers (Mackie et al., 2008;
Dennis et al., 2015). There was a consistent difference between the
expression of chondrogenic markers in bone and sponge samples
as noted by the sectioned Y axis. Indeed, at 16 days, in the former
these three genes were downregulated by both rhBMP2 and
strontium, with respect to HAn condition (Figure 8A). While
in the latter, both osteoinductive factors brought to significantly
higher expression of Col10A1 and Sox9 (Figure 8C), with an
enhanced effect in SrHAn loaded sponges. At 33 days, the
difference between the tissue samples is equalized and only
significant up-regulation of Sox9 in the bone and Acan in the
sponge were shown as strontium-driven effects (Figures 8E,G).
Expression of the stem cells recruitment marker, Nanog, showed
no significant difference at 16 days and only a mild up-regulation
with respect to control at 33 days in the sponge sample. After
16 days, a significant up-regulation of BGlap (Osteocalcin), Ibsp
(bone sialoprotein), and Sp7 (Osterix) was observed in the
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FIGURE 5 | Graphical representation of sponge weights variations. Untreated sample weights were measured with an analytical balance. Weights were recorded at
different time points throughout the 28 days in aqueous solution. Day 0 is referred to the unloaded sponge, whereas Day 1 corresponds to the loaded sponges and it
was considered the initial weight (Wi). N = 3 different sponges were weighted per each condition. From the recorded weights, we calculated the percentage weight
loss. Error bars indicate the standard deviation. Statistically significant differences were assessed with one way ANOVA. Significant differences were reported only
against day 1 (*p < 0, 05; **p < 0, 01; ****p < 0, 0001).
femur of mice that received the SrHAn implant compared to
HAn-BMP2 and to HAn samples alone (Figure 9A). Similar
results were observed with BGlap, Ibsp, and Sp7 expression being
evaluated in the sponge samples at 16 days (Figure 9D). In
both the femur and the sponge tissues Dmp1 (Dentin matrix
protein 1) was upregulated by strontium with respect to the
control HAn. A similar trend of expression was also detected
at 33 days, where Ibsp in the bone (Figure 9G) and Ibsp,
BGlap, and Sp7 in the sponge (Figure 9J) were upregulated
by strontium. Runx2 didn’t show significant differences in
expression at given time points. Sost (Sclerostin) expression
was analyzed as marker for osteocyte differentiation. After 16
days, Sost was upregulated in the strontium samples only with
respect to the control HAn, both in the bone and sponge samples
(Figures 9B,E). At 33 days, an up-regulation of Sost was observed
only in the bone samples loaded with strontium compared to
HAn-BMP2 and HAn (Figures 9H,K). Acp5 (Tartrate-resistant
acid phosphatase type 5), Rankl (Tumor necrosis factor ligand
superfamily member 11) and Ctsk (Cathepsin K) expression were
analyzed as markers for OCs differentiation and activity. At 16
days, Acp5 and Rankl (Figures 9C,F) were downregulated in
SrHAn femurs and sponges Ctsk at 16 days was upregulated
in femur and sponge by both types of osteoinductive factors
(Figures 9C,F). At 33 days, strontium presence led to an up-
regulation of Acp5 and down-regulation of Rankl only in the
bone samples (Figure 9I). Ctsk was down-regulated in SrHAn
implanted mice with respect to control, both in bone and sponge
samples (Figures 9I,L).
SrHAn loaded-sponge structure were suitable for the
promotion of cell invasion, bone marrow cell recruitment and
ossification. Following a lyophilization treatment (which could be
useful for sponge long-term storage and packaging), the loaded
sponges did not show significant variation from the untreated
samples and all physical-chemical properties were conserved.
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FIGURE 6 | X-ray images and macroscopic observation of mice implanted with loaded sponges. Images at 16 and 33 days of mice implanted with HAn
loaded-sponges (A,D,G,J,M,P, respectively), HAn-BMP2 loaded-sponges (B,E,H,K,N,Q) and SrHAn (C,F,I, L,O,R, respectively). The implanted sponges are shown
by black arrowheads. Isolated femurs are shown in panels (D–F) and (M–O). Isolated legs including implants are shown in panels (G–I) and (P–R).
The biodegradability and biocompatibility of the system was
proven in vivo, together with the induction of endochondral
ossification stages in adult bone. Evidence of endochondral
ossification were given in the histological investigation, where
proliferating and hypertrophic chondrocytes were more
represented in the strontium-containing samples than in
the BMP2 ones. Gene expression corroborated histological
evidences, showing increased expression of osteogenic and
chondrogenesis markers. Moreover, these data were consistent
with an enhancement of endochondral ossification in the
SrHAn samples if compared to the HAn-BMP2 samples.
Antiresorptive properties of strontium were also demonstrated
by investigating markers of osteoclasts differentiation and
activity. Histological and gene expression data further
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FIGURE 7 | Representative histological images of post-implants tissues of mouse limb. Fast green/Safranin-O staining was used on post-implant tissue sections of
limbs implanted with loaded sponges with HAn (A,D,G,J), HAn-BMP2 (B,E,H,K), or SrHAn (C,F,I,L), for 16 and 33 days, respectively. In the images, red spots of
cartilaginous tissue are indicated with red arrowheads and gray blurs of ectopic bone are highlighted with *. Black arrows and black arrowheads indicate femur bone
and sponges, respectively. The circle highlights a blood vessel.
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FIGURE 8 | Gene expression of stem cell recruitment and chondrogenesis markers in bone and sponge post-implants. Gene expression was analyzed in femur bone
(A,B,E,F) and sponge post-implant (C,D,G,H) samples at 16 (A–D) and 33 days (E–H), respectively. Expression of chondrogenesis markers Acan, Col10A1 and Sox9
(A,C,E,G) as well as stem cell recruitment marker Nanog (B,D,F,H) has been evaluated. The graphs show the inverse of the 11Ct at the power of 2. Bars indicate
mean values ± SEM of results from 4 experiments. Statistical significance values were calculated with one way-ANOVA, followed by Tukey’s honestly significant
difference test. *, significant difference against the HAn condition (p < 0.05). #, significant difference between HAn-BMP2 and Sr conditions (p < 0.05).
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FIGURE 9 | Gene expression of osteocytes, osteoclasts homeostasis, and osteogenic markers in bone and sponge post-implants. Gene expression was evaluated in
femur bone (A,B,C,G,H,I) and sponge post-implant (D,E,F,J,K,L) samples at 16 (A–F) and 33 (G–L) days, respectively. Expression of osteogenic markers Dmp1,
Bglap, Ibsp, Sp7 and Runx2 (A,D,G,J), osteocytes marker Sost (B,E,H,K) and osteoclasts relevant markers Acp5, Rankl and Ctsk (C,F,I,L) has been evaluated. The
graphs show the inverse of the 11Ct at the power of 2. Bars indicate mean values ± SEM of results from four experiments. Statistical significance values were
calculated with one way-ANOVA, followed by Tukey’s honestly significant difference test. *, significant difference against the HAn condition (p < 0.05). #, significant
difference between HAn-BMP2 and SrHAn conditions (p < 0.05).
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supported the osteoinductive and osteoconductive potential
of this system.
DISCUSSION
Bone tissue engineering application in the orthopeadic surgical
field is becoming increasingly relevant. In the last decades,
rhBMP2 was extensively studied for its osteoinductive potential.
Although several successful applications have been achieved, this
recombinant morphogen was proven to be not always suitable
and safe (Poon et al., 2016; Lykissas and Gkiatas, 2017). Another
powerful osteoinductive agent, strontium, was widely studied
in the previous years and compelling results were obtained in
term of biocompatibility and osteoconductivity (Boanini et al.,
2011; Yang et al., 2011). Strontium hydroxyapatite nanoparticles
were recently developed, carrying an inorganic osteoinductive
agent (Frasnelli et al., 2016). They have been characterized in
the last years and in this work, they are presented as a substitute
for rhBMP2.
In this study, the medical grade collagen-based Gelfoam
sponges were loaded with a combination of either calcium and
strontium hydroxyapatite nanoparticles suspensions (SrHAn)
or calcium hydroxyapatite nanoparticles and rhBMP2 (HAn-
BMP2) in order to compare their physical-chemical properties.
The HAn sponges were loaded only with calcium hydroxyapatite
nanoparticles and used as control. A second set of samples were
treated with an additional lyophilization step and characterized.
The hydroxyapatite nanoparticles amount on each sponge
was 30% (w/v) of the volume absorbed by the sponge and 3
µg of rhBMP2 per sponge were used for HAn-BMP2. For the
SrHAn loaded-sponges, the calcium/strontium hydroxyapatite
nanoparticles ratio was 9:1 w/w (Chandran et al., 2016) while
the spontaneously occurring Sr:Ca ratio is between 1:1,000
and 1:2,000 in human bone tissue as well as in blood serum
(Cabrera et al., 1999).
The cumulative amount of calcium and strontium ions after
28 days in aqueous solutions were measured as 0.0118 and
0.0358mg, respectively. Interestingly, several in vitro and in
vivo studies reported that strontium elicits rhBMP2-like effects
when administered at concentrations up to 1mM, as reported by
Schumacher et al. (2013) and others (Qiu et al., 2006; Li et al.,
2010; Schumacher et al., 2013;Wei et al., 2019). Despite the lower
water solubility of Sr2+ compared to Ca2+, we detected enhanced
strontium solubilization from the SrHAn sponges, compared to
the calcium release from the HAn sponges. These data are in
agreement with Kaufman and Kleinberg (1979) and Pan et al.
(2009) studies. They demonstrated how, due to a larger atomic
radius, strontium atoms slightly reduce hydroxyapatite lattice
thermodynamic stability, favoring the release of Sr2+ from the
lattice itself. Furthermore, ICP-OES results were comparable
to the ones presented by Landi et al. in term of ion release
pattern (Landi et al., 2007) and were not significatively influenced
by the lyophilization treatment. We investigated the sponge-
nanoparticle system through FT-IR analysis of the untreated and
treated systems (HAn, SrHAn, sHAn, and sSrHAn). Significant
interactions were not found between the sponge and either
HAn or SrHAn. FT-IR spectra of loaded sponges showed no
chemical interactions were undergoing between the sponges and
the nanoparticles. The minor shifting of the amide I and II
bands was attributed to hydrogen bonds breaking in the sponge
proteins and consequent modification of the hydrogen bonds
network in the sponge structure. We can therefore assume
that the ion release patterns studied with ICP-OES were not
influenced by chemical interactions between the nanoparticles
and the sponge support, either before or after the lyophilization
treatment. To illustrate the patterns of ion release in function
of time we considered the porous structure of the sponges. We
could speculate a bulk of nanoparticles flowed inside the sponge
pores, during the loading procedure. Nanoparticles remaining
on the sponge surfaces released a high percentage of Ca2+ and
Sr2+ ions during the first 3 days, while embedded nanoparticles
were responsible for the constant release recorded after day
3. The same speculation can also fit the data on rhBMP2
release. This hypothesis was corroborated by SEM images, that
showed smoother surfaces and solubilization of hydroxyapatite
aggregates at day 28. Surprisingly, even after 28 days in aqueous
solution, calcium and traces of strontium were still detected on
the sponge surfaces, as demonstrated by SEM-EDS data.
Interestingly, the calcium release pattern of HAn-BMP2
loaded-sponges was different from the other samples. This can be
due to the non-covalent interaction between HAn and rhBMP2
(Urist et al., 1984; Boix et al., 2005). We were not able to
investigate HAn-BMP2 loaded-sponges with FT-IR, since this
technique is not able to discern between different proteins. We
can speculate that calcium ions remained bound to solubilized
rhBMP2, therefore decreasing the amount of free Ca2+ released
in solution.
Pore sizes ranging between 100 and 300µm are considered
the most suitable for osteoinduction improvement as well
as for angiogenesis promotion (Karageorgiou and Kaplan,
2005; Scheinpflug et al., 2018). Furthermore, geometry of the
investigated sponges reflected the “gold standard” in bone tissue
engineering, according to Kuboki et al. (2007) and due to the
given pores size and geometry the surface area exposed to
the surrounding microenvironment is increased, allowing for
a wider interaction between the nanoparticles coating and the
surrounding microenvironment.
The degradability and recyclability of the graft is a
crucial point, although often disregarded, in tissue engineering
applications (Gentleman et al., 2010; Rohnke et al., 2016). In
this work, the time-dependent biodegradability of the sponges
and the hydroxyapatite nanoparticles both in the abiotic and in
vivo conditions, were analyzed. Degradation pattern based on the
sponge weights appearedmild but significant for SrHAn sponges,
throughout the 28 days in solution. While, in vivo radiographic
images and histology suggested an accelerated degradation of
SrHAn sponges. Radiographic images also revealed an induction
of bone formation and osseointegration by all three types
of implants at both time points. Although, a more extensive
mineralized tissue in mice implanted with HAn-BMP2 and
SrHAn sponges were shown with respect to the controls.
Histological analysis revealed new tissue formation between the
sponge and the femoral cortex, suggesting a center of active
osteogenesis was present in the sponge site. Given the similarities
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 14 June 2020 | Volume 8 | Article 499
Montagna et al. Strontium Hydroxyapatite Nanoparticles for Bone Regeneration
between Ca2+ and Sr2+, it has been shown that this element can
substitute calcium in the lattice of the hydroxyapatite crystals
present in bones (Ni et al., 2011; Querido et al., 2016). Sr2+ is
processed like Ca2+ throughout metabolism, being preferentially
introduced in active osteogenesis sites (Bauman et al., 2005).
RhBMP2 and Sr2+ release was quantified using different
techniques, therefore it is not possible to compare their
quantities/concentrations in solution head-to-head. Despite the
similarities in the pattern release between HAn-BMP2 and
SrHAn, strontium containing nanoparticles induced significant
increase of endochondral ossification markers. It is well-
known how the process of endochondral ossification can be
recapitulated in adults by bone fracture and bone tissue damage
(Gerstenfeld et al., 2003; Dennis et al., 2015), although in this
work evidences of endochondral ossification were induced in
healthy implanted mice, with no bone damage. Furthermore, no
record of strontium related-endochondral ossification induction
is present up to date, but here at 16 days the onset of typical
multicellular clusters constitutes by enlarged chondrocyte was
demonstrated (Mackie et al., 2008). Hypertrophic chondrocytes
can be detected in the sponge surroundings at 16 days,
together with smaller proliferating chondrocytes. These were
particularly represented in the HAn and SrHAn samples and
red stained-cartilage proteoglycans were present all around the
cells. Hypertrophic chondrocytes were almost absent in the HAn-
BMP2 samples, suggesting a possible delay or acceleration in
chondrogenic differentiation. Different phases of endochondral
ossification process were shown also by gene expression data:
Sox9 upregulation was an indicator of chondrocytes proliferation
(Akiyama et al., 2002; Lefebvre and Dvir-Ginzberg, 2017) and
after its downregulation, markers of hypertrophic chondrocytes,
such as aggrecan core protein (Acan) and type X collagen
(Col10A1) were upregulated (Akiyama and Lefebvre, 2011).
We can speculate that the different temporal upregulation of
Sox9, among bone and sponges, can be attributed to the time
dependent Sr2+ diffusion, which resulted in its earlier expression
in the sponge area and delayed expression in the bone one.
The interaction of Sr2+ with the calcium-sensing receptor
(CaSR) was shown both in OBs and osteoclasts (OCs), resulting
in improved anabolic processes and reduced catabolic pathways,
respectively (Chattopadhyay et al., 2006). Our gene expression
data showed SrHAn double activity on OBs and OCs. Several
studies reported that strontium modulates alkaline phosphatase
(ALP) activity and Runx-2 expression (Tian et al., 2014) in
OBs and OBs progenitors while promoting Wnt/β-catenin
pathway in human bone marrow derived mesenchymal stem
cells (MSCs), thereby enhancing ECM secretion and osteogenic
differentiation (Yang et al., 2011). Interestingly, in our study no
significant variation was detected in Runx2 levels. However, our
results measured an upregulation of Sp7 (Osterix), indicating
OBs differentiation at early and late stage (Santo et al., 2013;
Kawane et al., 2018). Sp7 is a transcriptional factor expressed in
developing bones regulating the commitment of MSCs toward
osteoblastic lineage (Rutkovskiy et al., 2016). Its regulation
affects expression of protein-coding genes typically related to
osteoblastic differentiation, such as osteocalcin, type I collagen
and bone sialoprotein (BGlap, Ibsp, and Dmp1). Increased
expression of the ECM proteins BGlap, Ibsp, and Dmp1
was attributed to mature osteoblasts activity (Wrobel et al.,
2016) in SrHAn samples. Sp7, BGlap, and Ibsp expression
also indicated a stronger osteogenic induction for strontium
ions compared to rhBMP2. Interestingly Runx2, the master
regulator of osteoblastic differentiation acting above Sp7, was
not significantly influenced neither by strontium nor by rhBMP2
(Nakashima et al., 2002). Soluble cytokine promoting OCs
differentiation, Rankl, (expressed by OBs) is a key modulator
of the resorption cycle, controlling OCs differentiation and
activation, and therefore bone resorption. This molecule has
already been linked to strontium-mediatedmodulation by Atkins
et al. (2009) and Brennan et al. (2009). Our results showed
strontium significantly downregulated Rankl when compared
to control and HAn-BMP2 samples. It has been shown that
strontium effects are mediated by CaSR and by others, yet
unclarified receptors (Chattopadhyay et al., 2006; Takaoka et al.,
2010; Saidak and Marie, 2012). Furthermore, being CaSR present
also on OCs outer membrane it was demonstrated the action of
strontium on OCs activity. Indeed, OCs-secreted endoprotease
responsible for ECM degradation (Sage et al., 2012), Ctsk
(Cathepsin K) was reduced by strontium presence at 33 days,
with respect to the control. Of note, in some of the SrHAn
sponges we observed vascularization, suggesting a potential effect
of Sr2+ on neo-vascularization, although further studies are
needed to confirm these findings.
CONCLUSIONS
Many studies have been conducted to investigate rhBMP2
suitability as treatment for spinal fractures and critically-sized
bone defects. Although its indisputable osteoinductive potential,
rhBMP2 also showed adverse effects. On the other hand,
strontium has already been tested as a treatment for osteoporosis
and its activity was demonstrated in a patient population.
The biggest advantage of strontium over rhBMP2 however,
is that the former is a chemical and not a biologic. Herein,
following the abiotic characterization, we presented the results
of a comparative in vivo study, where Gelfoam sponges loaded
either with strontium hydroxyapatite nanoparticles or with
rhBMP2 were implanted in healthy, bone damage-free mouse
model. In vivo studies, showed that SrHAn and HAn-BMP2
have comparable effects, driving the onset of endochondral
ossification and promoting the bone remodeling process. These
results demonstrated that SrHAn loaded-sponges have marked
osteogenic potential when applied on the periosteum of long
bones, comparable to HAn-BMP2 loaded-sponges, but eliciting
a more controlled ossification response. We propose to use
Gelfoam sponges enriched in Sr2+ as an effective therapeutic
intervention to treat severe bone defects or open, complicated
fractures. The short-term benefit of this nanotechnological
system is the availability of novel therapeutic option to treat
bone fracture (or bone defect). The use of sponges loaded with
strontium hydroxyapatite nanoparticlesmight also provide better
outcomes for complex fractures. Results from these studies can
provide novel therapeutic options for active duty personnel
and can be beneficial to anyone suffering from trauma, bone
defects or severe bone injuries. Future studies shall also evaluate
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the efficacy of SrHAn loaded sponges for the treatment of
spinal fusion.
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